Drug Detail:Linagliptin (Linagliptin [ lin-a-glip-tin ])
Drug Class: Dipeptidyl peptidase 4 inhibitors
Drug Detail:Linagliptin (Linagliptin [ lin-a-glip-tin ])
Drug Class: Dipeptidyl peptidase 4 inhibitors
Recommended dose: 5 mg orally once a day
Comments: When used in combination with insulin or an insulin secretagogue, a lower dose of the insulin secretagogue or insulin may be necessary to reduce the risk of hypoglycemia.
Use: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
No dose adjustment recommended.
No dose adjustment recommended.
Safety and efficacy have not been established in patients younger than 18 years.
Consult WARNINGS section for additional precautions.
No adjustment recommended.
Administration advice: